The Norwegian Cancer Society present research they support regularly, in a popular science form.
Olav Engebråten from the Department of Oncology at OUH has recently (October 10th) been interviewed about The NeoAva study he is leading - a clinical breast cancer study for patients with tumors more than 2.5 cm in diameter, where treatment with bevacizumab is involved - a substance (antibody) that binds and removes one of the factors (VEGF) excreted from the cancer cells that may stimulate the growth of blood vessels. The treatment can therefore prevent blood vessels from growing into the tumor tissue, and enhance the effect of the chemotherapy in the tumor.
Welcome to the next Oslo University Hospital (OUH) research seminar entitled:
Individualized cancer treatment
Time: Monday, October 9th, 2017, at 14:30 – 16:00
Place: Blue Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo
Speakers: Kjetil Taskén, Eivind Hovig, Gunhild Mælandsmo, Arnoldo Frigessi, Yngvar Fløisand
A project involving the generation of induced pluripotent stem cells (iPSCs) from Norwegian patients with Parkinsons disease was recently featured on the evening news broadcast from the Norwegian Broadcasting Corporation (NRK). This project - a collaboration between neurologist Mathias Toft, project group leader at the Department of Neurology at Oslo University Hospital and Gareth Sullivan, group leader at the Stem Cell Center - aims to generate neurons from the patient-derived iPS cells and to investigate disease mechanisms in these. The project is an example of the activities supported by The Neuron Factory platform at the Norwegian Center for Stem Cell Research.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) has appointed Tor Inge Tønnessen from the Anaesthesia & Intensive Care Research Group at the Division of Emergencies and Critical Care at Oslo University Hospital as "Researcher of the month" for the month of September 2017.
The Norwegian bioinformatics company OncoImmunity and the Norwegian Cancer Genomics Consortium (NCGC) at Oslo University Hospital announce September 20th that they have entered into a collaboration with the American "Sarcoma Alliance for Research through Collaboration" (SARCtrials.org), to search for active neoantigens and related immune biomarker signatures of response in an American clinical trial on sarcoma patients treated with the PD1 immune checkpoint inhibitor pembrolizumab.
This event is open to all, and is designed to help inform Norwegian scientists about the training opportunities, services and infrastructure available at the EMBL (European Molecular Biology Laboratory). The meeting is sponsored by the EMBL Alumni Association, and has received funding from UiO: Life Science and the Research Council of Norway.
Date & Time: 9am-6pm, Friday 29 September 2017
Location: University Library Auditorium 1, Georg Sverdrup Hus, Blindern, University of Oslo.
On Thursday September 14th The Institute for Cancer Research had the honour of hosting this year´s Jahre Prize winners for their lectures.
The lectures were by three of the leading scientists in the Nordic countries. The main prize winner (Christer Betsholtz) and one of the junior prize winners (Simon Bekker-Jensen) have their background in cancer research.
We would like to extend an invitation to The Norwegian Cancer symposium 2017 on Precision Medicine.
It will take place at Scandic Holmenkollen Park, December 4-6, 2017 in Oslo, Norway.
The meeting gathers leading national and international speakers in the field of precision medicine, and topics include the following:
His Majesty The King has appointed Professor Emerita Anne-Lise Børresen-Dale as Commander of the Royal Norwegian St. Olavs Order for her outstanding efforts in medical research.
The decoration was be presented at an event in the Research Building at Radium Hospital in Oslo August 28.
The European Research Council (ERC) has awarded a Starting Grant 2017 to Kyrre Eeg Emblem from Department of Diagnostic Physics at the Divsion of Radiology & Nuclear Medicine. This is the seventh ERC Starting Grant awarded to Norway in the main panel Life Sciences (LS), and the first time Oslo University Hospital is the host institution.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) has appointed Tone Rustøen from the Nursing Research Group at the Division of Emergencies and Critical Care at Oslo University Hospital as "Researcher of the month" for the month of July.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of June 2017, this honour went to professor Håvard Danielsen, head of the Institute for Cancer Genetics and Informatics at OUH.
A portion of bone cancers may respond to existing insulin-like growth factor 1 receptor inhibitors because they carry mutations in IGF signaling genes, a study recently published in Nature Communications suggests. The sarcoma team at the Norwegian Radium Hospital at Oslo University Hospital was represented in this study by Bodil Bjerkehagen, the sarcoma reference pathologist, Olga Zaikova, on behalf of the orthopedists, and Ola Myklebost, PI in the ICGC Bone Cancer Project. This study is a side branch from their previous participation in the European Network of Excellence on Bone Tumours, and is carried out by the International Cancer Genomics Consortium at the Sanger Centre in Hinxton outside Cambridge.
Professor Øyvind Sverre Bruland, senior consultant oncologist at the Department of Oncology at the Division of Cancer Medicine, has been interviewed in connection with being appointed "Innovator of the Month" by South-Eastern Norway Regional Health Authority (Helse Sør-Øst). His clinical experience and research are mainly devoted to primary bone and soft tissue cancers (sarcomas) and skeletal metastases from prostate cancer and breast cancer. In particular, targeted radionuclide therapy, e.g. Alpharadin (Algeta), based on Radium-223, is currently at center stage.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
For the month of May 2017, this honour went to Lars Tjelta Westlye, senior scientist at the The Norwegian Centre for Mental Disorders Research (NORMENT). The centre is based on a collaboration between the University of Oslo (host institution), the University of Bergen and Oslo University Hospital, where Westlye has a position at the psychosis research section at the Division of Mental Health and Addiction.
The South-Eastern Norway Regional Health Authority hereby announces a call for applications for research projects and research activities starting in 2018.
The total funding available for this call is approximately 100 million Norwegian kroner.
Application deadline is Tuesday, September 5th 2017 kl. 16:00.
Six research groups were awarded for their excellent papers published during the second half-year of 2016 during a ceremony June 16th. Each group received NOK 50.000 for use in further research. The prize winners gave short presentations of the main findings in their respective articles.
The six selected articles are of especially high quality, and they present important finding on both-short and long-term scales. The works reflect the good quality and the interdisciplinarity that characterises several research environments at Oslo University Hospital. The research is a fundamental condition for the institution to maintain and strenghten the quality in the patient treatment.
Microsatellite instability (MSI) defines a small subgroup of approximately 15% of colorectal cancers (CRC) which currently receives much attention due to its overall good response to immune-checkpoint inhibition. In the latest issue of Genome Medicine, scientist Anita Sveen and colleagues publish the largest multilevel genetic analysis of this tumor type reported to date, describing substantial inter- and intra-tumor heterogeneity. The clinical importance of these results, in particular with respect to the optimized use of immunotherapeutics for treatment of human cancers, was emphasized in a Research Highlight in the same issue of the journal.
King Olav V's cancer research prize for 2017 was on June 6th given to professor Per O. Seglen, formerly head of the Proteomics & Mammalian Cell Biology Section at the Institute for Cancer Research, OUH, currently a guest researcher at NCMM.
The prestigious prize is distributed annually by the Norwegian Cancer Society, and the winner receives NOK 1.000.000.
Norwegian scientists have found the genetic cause of the skin disease KWE (keratolytic winter erythema) - a rare autosomal-dominant skin disorder characterized by recurrent episodes of palmoplantar erythema and epidermal peeling, usually triggered by cold weather, moisture, or stress.
In an article recently published in the American Journal of Human Genetics (journal impact factor 10.8) it is concluded that KWE is caused by tandem duplications in a non-coding genomic region containing an active enhancer element for CTSB, a gene encoding cathepsin B, resulting in upregulation of the protein in affected individuals.
The article was selected as "Editors choice" in AJHG for the month of May.
Head physician and 2nd author of the paper Jan Cezary Sitek (photo) from the Dermatology Research Group at Oslo University Hospital initiated the research project six years ago, and treats several patients with KWE.
|Previous news articles|
|Norwegian research with international impact Less expensive medicine results in treatment for more patients|
|The 2017 Excellent Research Awards to Kirsten Sandvig, Johannes Espolin Roksund Hov and Tor Paaske Utheim|
|Organ donation for abdominal and thoracic organs OUH research seminar, Monday, May 8th 14:30 - 16:00|
|Placing my research in an H2020 project Program Info - workshops held May 8-9th:|
|New insight into late effects after cancer treatment presented by the Norwegian Cancer Society|
|Immunotherapy for Cancer OUH research seminar, Tuesday, April 25th 10:00 - 15:45|
|Study on replication fork stability from Skarstad group published in Nucleic Acids Research|
|Innovation to Finance Research OUH research seminar, Monday, April 3rd 14:30|
|NORMENT researchers contribute to PLOS Medicine article on genetic assessment of age-associated Alzheimer's disease risk|
|The AACR-WICR Friend Lectureship presented to Anne-Lise Børresen-Dale|
|CanCell a new Centre of Excellence will reprogram cancer cells|
|Jørgen Wesche appointed group leader for the Mesenchymal Cancer Biology Group at the Department of Tumor Biology New group leader at the Institute for Cancer Research:|
|Prestigious research prize from the Norwegian Cancer Society to pioneer in autophagy research King Olav V´s Cancer Research Prize to Per O. Seglen (07.03.2017 10:32)|
|Health after transplantation OUH research seminar, Monday, March 6th 14:30 (07.03.2017 10:32)|
|Early signs of mental illness in the developing brain NORMENT study published in Nature Neuroscience: (07.03.2017 10:32)|
|Arne Klungland talks about embryo research Breakfast lecture in Oslo Wednesday March 1st: (07.03.2017 10:32)|
|Thon Awards seminars 2017 Invitation to seminar March 2nd 12:00 (07.03.2017 10:32)|
|Critical article on doping and drug testing published in EMBO reports (07.03.2017 10:32)|
|Early phase drug development: From idea to concept OUH research seminar, Monday, February 6th 14:30 (07.03.2017 10:32)|
|"Science" article from Johanna Olweus's group highlighted by editorial in New England Journal of Medicine (07.03.2017 10:32)|
|6th National Conference on Stroke Oslo Kongressenter, February 09-10 2017 (07.03.2017 10:32)|
|Theis Tønnessen appointed "Scientist of the Month" by "Helse Sør-Øst" for January 2017 (07.03.2017 10:32)|
|Sepsis: New definitions and future research OUH research seminar, Thursday, January 26th (07.03.2017 10:32)|
|Excellent Researcher Award and Early Career Award 2017 Announcement: Nominating outstanding scientists, closing date March 1st: (07.03.2017 10:32)|
|Antimicrobial resistance - how bad is the situation in the world of virus, fungus and mycoplasma? OUH research seminar, Monday, January 16th (07.03.2017 10:32)|
|Findings from Rusten group published in Nature on microenvironmental autophagy draw nationwide attention Updated: honoured with "Preview" article in Developmental Cell (07.03.2017 10:32)|
|Commentary article from Arne Klungland in Nature Methods on epitranscriptome analysis (07.03.2017 10:32)|
|Research funding from South-Eastern Norway Regional Health Authority for 2017 (07.03.2017 10:32)|
|Educating future cancer researchers from Ullern high school (07.03.2017 10:32)|
|Novel cancer immunotherapy published in Cancer Research, with cover illustration (07.03.2017 10:32)|
|Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2016 (07.03.2017 10:32)|
|Oslo University Hospital research seminar: Exercise and Brain Energy Monday, November 21st, 2016, at 14:30 16:10 (07.03.2017 10:32)|
|Oslo University Hospital research seminar: The World of Immunology Thursday November 17th at 10:00-15:00 (07.03.2017 10:32)|
|Oslo University Hospital researchers receive 77.3 mill NOK from the Norwegian Cancer Society Results of Open Call 2016: (07.03.2017 10:32)|
|Human lung macrophages are self-maintained for several years (07.03.2017 10:32)|
|Announcement of research funding from the Norwegian Cancer Society Gathering Friday October 28th 10-12 at UiO: (07.03.2017 10:32)|
|Dag Berild awarded the "Akademikerprisen" for his work on antibiotic resistance (07.03.2017 10:32)|
|50 years anniversary Institute for Surgical Research Thursday 13 October 2016 at 10.15 AM (07.03.2017 10:32)|
|Making therapeutic antibodies from scratch (07.03.2017 10:32)|
|Lina Prasmickaite's work presented in popularised form (07.03.2017 10:32)|
|Medical imaging in cardiac research Oslo University Hospital research seminar Monday October 10th (07.03.2017 10:32)|
|Focus on personalized medicine and the MetAction study (07.03.2017 10:32)|
|Histone marks regulate maternal-to-zygotic transition Paper from Dahl/Klungland published in the Sep 22nd issue of Nature (07.03.2017 10:32)|
|Turning the tide of antimicrobial resistance National kick-off, Tuesday September 13th (07.03.2017 10:32)|
|Marina Vietri interviewed for major Italian research web portal (07.03.2017 10:32)|
|OUH researchers publish groundbreaking computer tools for cell biology research in Nature Methods (07.03.2017 10:32)|
|POLE proofreading domain mutations identify a subset of immunogenic colorectal cancers with excellent prognosis (07.03.2017 10:32)|
|Clinical Cancer Research highlights biomarker paper from Lyngs group (07.03.2017 10:32)|
|The Norwegian Cancer Genomics Consortium participates in international study of gene variants predisposing for cancer development. (07.03.2017 10:32)|
|Annuncement of research funding from South-East Norway regional health authority for 2017 Call for applications 2017 (07.03.2017 10:32)|
|H.M. the King's Gold Medal to Marina Vietri (07.03.2017 10:32)|
|Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2015 (07.03.2017 10:32)|
|Atle Bjørnerud "Innovator of the Month" South-Eastern Norway Regional Health Authority brings attention to innovation: (07.03.2017 10:32)|
|Tomas Lindahl, Nobel Prize laureate 2015 Symposium at OUS, Rikshospitalet, 17. June 2016 13:00-15:30 (07.03.2017 10:32)|
|The 2016 Excellent Research Awards to Pål Aukrust, Therese Seierstad and Espen Melum Oslo University Hospital honouring outstanding scientific work: (07.03.2017 10:32)|
|Strønen and Olweus publish article in Science on the use of donor immunity to target cancer (07.03.2017 10:32)|
|Håvard Danielsen and Erik Fosse receive Lighthouse project grants from the Norwegian Research Council (07.03.2017 10:32)|
|"Intelligent needle tracking using ultrasound imaging for improved minimally invasive interventions" supported by EU OUS scientists partners in project funded by HORIZON 2020 FAST TRACK TO INNOVATION (07.03.2017 10:32)|
|Discovery of biologically active small molecular compounds Oslo University Hospital research seminar Monday May 9th (07.03.2017 10:32)|
|Mapping somatic mutations in breast cancer whole genomes OUS scientists co-author Nature article: (07.03.2017 10:32)|
|Same, but different? Genetic analysis of five immune mediated diseases reveals molecular taxonomy of chronic inflammation (07.03.2017 10:32)|
|Immunotherapy for Cancer Day of Immunology Conference 2016 April 29 (07.03.2017 10:32)|
|New guidelines for "Helse Sør-Øst" and "Kreftforeningen" applications Information meeting, Radiumhospitalet, Friday April 22nd (07.03.2017 10:32)|
|Ståle Nygård Dept. of Core Facilities Institute seminar April 6th (07.03.2017 10:32)|
|Article published in Science Translational Medicine showing that cyclodextrin may reduce atherosclerosis attracts worldwide attention (07.03.2017 10:32)|
|The Fridtjof Nansen Award for Young Scientists for 2016 to Kyrre Eeg Emblem (07.03.2017 10:32)|
|Theodossiou and Berg funded by the Future and Emerging Technology (FET) program (07.03.2017 10:32)|
|King Olav V's cancer research prize for 2016 to Kjetil Taskén (07.03.2017 10:32)|
|Morgendagens medisin The Norwegian Inflammation Network seminar Wednesday March 16th (07.03.2017 10:32)|
|Microbiome Oslo University Hospital research seminar Monday March 14th (07.03.2017 10:32)|
|Liliane Christ identifies mechanism for regulation of daughter cell separation (07.03.2017 10:32)|
|NoPSC study of PSC gut microbiota published in Gut (07.03.2017 10:32)|
|Olav Thon Foundation's International Prize and Research Awardees 2016 Invitation to seminar March 3rd 12:00 (07.03.2017 10:32)|
|Stephen H. Friend Norsk Hydro's Fond guest lecture March 10th (07.03.2017 10:32)|
|Ragnhild A. Lothe and Michael Bretthauer substantially supported by FRIPRO (07.03.2017 10:32)|
|Filming live cancer cells Camilla Raiborg's work presented in popularised form on forskning.no: (07.03.2017 10:32)|
|Elderly patients benefit from an early invasive strategy Heart study results recently published in Lancet attract attention: (07.03.2017 10:32)|
|Lorenz et al. published an extensive study investigating the genomic chaos in osteosarcoma (07.03.2017 10:32)|
|Personalized Cancer Care Symposium, Oslo, May 18-20, 2016 (07.03.2017 10:32)|
|Åslaug Hellands research on lung cancer presented by the Norwegian Cancer Society (07.03.2017 10:32)|
|Innovation projects funded by the Norwegian Cancer Society and Research Council (07.03.2017 10:32)|
|Medical imaging in cancer biology and personalized therapy Oslo University Hospital research seminar January 11th (07.03.2017 10:32)|
|Sandvig received INNO INDIGO grant for work with biodegradable nanoparticles (07.03.2017 10:32)|
|Work from Bjørås' group published in "Cell Report" (07.03.2017 10:32)|
|Research funding from South-Eastern Norway Regional Health Authority for 2016 (07.03.2017 10:32)|
|AACR Recognizes Dr. Anne-Lise Børresen-Dale With 2015 Distinguished Lectureship in Breast Cancer Research (07.03.2017 10:32)|
|Erik Boye - an internationally renowned scientist retires (07.03.2017 10:32)|
|Oslo University Hospital has awarded 6 excellent articles for the first half-year of 2015 (07.03.2017 10:32)|
|New PhD Andreas Hoff publishes testis cancer fusion genes in Cancer Research (07.03.2017 10:32)|
|Asta Juzeniene - Dept. of Radiation Biology Institute Seminar Wednesday 9th of December at 12:00 (07.03.2017 10:32)|
|Findings regarding a novel non-genomic tamoxifen cytotoxic action published in ACS Chemical Biology (07.03.2017 10:32)|
|Tor Espen Thorvaldsen with cover story in Molecular Cancer Research (07.03.2017 10:32)|
|Oslo University Hospital researchers receive 92 mill NOK from the Norwegian Cancer Society (07.03.2017 10:32)|
|Ragnar Mørk legacy prize 2015 to Guro E. Lind Ceremony Friday November 20th (07.03.2017 10:32)|
|The first-in-man Phase I clinical trial of the EpCAM-targeting immunotoxin MOC31PE (07.03.2017 10:32)|
|Research on sonoactivatable nanoparticles funded by EuroNanoMed II ERA-NET program (07.03.2017 10:32)|
|Research on nanoparticle radiosensitizers funded by Euronanomed II ERA-NET program (07.03.2017 10:32)|
|PCI research funded by Euronanomed II ERA-NET program (07.03.2017 10:32)|
|Jørgen Wesche Dept. of Molecular Cell Biology Institute Seminar Wednesday 4th of November at 12:00 (07.03.2017 10:32)|
|New gold-standard for miRNA annotations published in Annual Reviews of Genetics (07.03.2017 10:32)|